Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.260
+0.060 (1.87%)
At close: May 8, 2026, 4:00 PM EDT
3.220
-0.040 (-1.23%)
After-hours: May 8, 2026, 7:57 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.02 billion as of May 8, 2026. Its market cap has decreased by -59.60% in one year.
Market Cap
1.02B
Enterprise Value
2.41B
1-Year Change
-59.60%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.02B, an increase of 234.91%. That is a compound annual growth rate of 24.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.02B | -36.45% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow | 1.42B |
| Collegium Pharmaceutical | 1.22B |
| Xeris Biopharma Holdings | 1.13B |
| Evotec SE | 1.08B |
| Cronos Group | 971.11M |
| Pacira BioSciences | 910.90M |
| Amphastar Pharmaceuticals | 837.77M |
| Eton Pharmaceuticals | 811.22M |